Patent Application Titled "Small Molecule Degraders Of Stat3" Published Online (USPTO 20230083015).

Předmět:
Zdroj: Cancer Weekly; 4/4/2023, p1675-1675, 1p
Abstrakt: STAT3 inhibitors are useful in treating or preventing diseases or conditions such as cancer wherein the inhibition of STAT3 provides a benefit. These compounds are STAT3 degraders or synthetic intermediates that can be converted to STAT3 degraders. STAT3 and/or STAT3/STAT1 degraders are useful in treating or preventing diseases or conditions such as cancer wherein the degradation of STAT3 or STAT3 and STAT1 provides a benefit. [Extracted from the article]
Databáze: Complementary Index